Understanding Breast Cancer Through Gene Expression Analysis
Author Information
Author(s): Wirapati Pratyaksha, Sotiriou Christos, Kunkel Susanne, Farmer Pierre, Pradervand Sylvain, Haibe-Kains Benjamin, Desmedt Christine, Ignatiadis Michail, Sengstag Thierry, Schütz Frédéric, Goldstein Darlene R, Piccart Martine, Delorenzi Mauro
Primary Institution: Swiss Institute of Bioinformatics, University of Lausanne
Hypothesis
How are different gene expression signatures related with respect to prognostication in breast cancer?
Conclusion
This meta-analysis unifies various results of previous gene expression studies in breast cancer, highlighting the important role of proliferation in breast cancer prognosis.
Supporting Evidence
- The study consolidated nine prognostic signatures associated with ER signaling, ERBB2 amplification, and proliferation.
- All nine prognostic signatures exhibited similar prognostic performance in the entire dataset.
- Proliferation activity was found to be the main contributor to the prognostic abilities of the signatures.
Takeaway
Scientists looked at a lot of breast cancer data to find out how different tests can tell us about the disease and how it behaves.
Methodology
The study performed a meta-analysis of publicly available breast cancer gene expression and clinical data from 2,833 tumors, using gene coexpression modules to analyze prognostic signatures.
Potential Biases
Potential biases from the datasets used, as they may not represent all breast cancer subtypes equally.
Limitations
The study may not account for all biological processes involved in breast cancer and relies on existing datasets, which may have biases.
Participant Demographics
The study included data from 2,833 breast cancer patients, but specific demographic details are not provided.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website